[{"Assets_0_Q3_USD":33734000000.0,"CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q3_USD":0.4,"CommonStockDividendsPerShareDeclared_3_Q3_USD":1.2,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":1.16,"EarningsPerShareBasic_3_Q3_USD":2.3,"EarningsPerShareDiluted_1_Q3_USD":1.16,"EarningsPerShareDiluted_3_Q3_USD":2.3,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":3511000000.0,"NetIncomeLossConverted_1_Q3_USD":1901000000.0,"NetIncomeLossConverted_3_Q3_USD":3760000000.0,"OfficialName":"Bristol-Myers Squibb Company Common Stock","RevenuesConverted_1_Q3_USD":5691000000.0,"RevenuesConverted_3_Q3_USD":16588000000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":13750000000.0,"StockholdersEquity_0_Q3_USD":13640000000.0,"Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1636000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1637000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1632000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1633000000.0,"filed":"20181025","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2018.0","name":"BRISTOL MYERS SQUIBB CO","period":"20180930","qtrs":"0","uom":"USD"}]